Dr. Ingo Lämmermann
– post-doc with 7 years of experience in aging research, who formed the hypothesis on which this project is based on. Inventor of two patents, of which one is already translated into a product.
Assoc. Prof. Johannes Grillari
– Head of the LBI for trauma and regeneration and the CD Laboratory for the Biotechnology of Skin Aging; Co-founder of TAmiRNA and Evercyte; 14 patents filed; > 130 peer-reviewed articles
– CEO of Chorus, Evercyte, Syconium, InnoFly Management; CFO of TAmiRNA, Phoenestra; from 1981 - 2007 department head at Boehringer Ingelheim Austria.
Published by RockFishBio
Share on Facebook
Share on Twitter
Share on LinkedIn